why choose us

First received: February 27, 2023

Clinical Trial: SB17170 Phase1 Trial in Healthy Volunteer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Safety Issues

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dosing, Dose-escalation, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, PK/PD, Food Effect, and Ethnicity Effect

Brief Summary: This clinical trial aims to learn about the safety, tolerability, and pharmacokinetic properties of SB17170 and its active metabolite SB1703 in single and multiple oral administration in healthy adults.The main questions it aims to answer are the safety, tolerability, and PK characteristics of SB17170 in healthy adults.

Read more